Gf Fund Management Co. Ltd. Nuvalent, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,378 shares of NUVL stock, worth $100,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,378Holding current value
$100,662% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
232Shares Held
57.7MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.31 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$392 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$221 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$191 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.14B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...